Employees: 11 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 1997-10-13 (28 years)Status: ActiveBusiness sector: Conseil pour les affaires et autres conseils de gestionLocation: LAVAL (53000), Mayenne
EVIDENCE SANTE : revenue, balance sheet and financial ratios
EVIDENCE SANTE is a French company
founded 28 years ago,
specialized in the sector Conseil pour les affaires et autres conseils de gestion.
Based in LAVAL (53000),
this company of category PME
shows in 2022 a revenue of 1.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - EVIDENCE SANTE (SIREN 414108043)
Indicator
2024
2023
2022
2021
2020
2017
2016
2015
2014
2013
Revenue
N/C
N/C
1 082 302 €
N/C
N/C
1 660 617 €
1 665 422 €
1 442 763 €
1 215 761 €
1 011 568 €
Net income
208 017 €
26 777 €
-316 618 €
781 €
-265 497 €
45 759 €
44 335 €
47 765 €
76 027 €
6 494 €
EBITDA
N/C
N/C
34 327 €
N/C
N/C
35 324 €
73 001 €
73 567 €
95 769 €
31 163 €
Net margin
N/C
N/C
-29.3%
N/C
N/C
2.8%
2.7%
3.3%
6.3%
0.6%
Revenue and income statement
In 2024, EVIDENCE SANTE generates positive net income of 208 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2013-2024: 6 k€ -> 208 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
208 017 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 9388%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 0%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
9388.353%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
0.216%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2013
2014
2015
2016
2017
2020
2021
2022
2023
2024
Debt ratio
198.095
109.042
125.769
80.309
79.82
-2717.129
-3110.299
-87.682
-80.671
9388.353
Financial autonomy
13.666
23.839
21.939
24.357
25.939
-1.605
-1.533
-54.771
-64.54
0.216
Repayment capacity
3.362
1.988
0.637
0.24
0.388
None
None
6.919
None
None
Cash flow / Revenue
1.14%
6.774%
3.917%
3.27%
1.353%
None%
None%
2.581%
None%
None%
Sector positioning
Debt ratio
9388.352024
2022
2023
2024
Q1: 0.0
Med: 4.0
Q3: 41.75
Average+50 pts over 3 years
In 2024, the debt ratio of EVIDENCE SANTE (9388.35) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
0.22%2024
2022
2023
2024
Q1: 4.27%
Med: 38.89%
Q3: 76.46%
Average
In 2024, the financial autonomy of EVIDENCE SANTE (0.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
6.92 years2022
2022
Q1: 0.0 years
Med: 0.0 years
Q3: 1.03 years
Average
In 2022, the repayment capacity of EVIDENCE SANTE (6.92) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 118.74. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
118.742
Liquidity indicators evolution EVIDENCE SANTE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2013
2014
2015
2016
2017
2020
2021
2022
2023
2024
Liquidity ratio
112.949
180.204
123.841
126.009
130.388
163.822
177.461
74.685
74.063
118.742
Interest coverage
40.962
13.825
11.902
16.959
32.42
None
None
38.366
None
None
Sector positioning
Liquidity ratio
118.742024
2022
2023
2024
Q1: 138.89
Med: 313.79
Q3: 966.61
Average
In 2024, the liquidity ratio of EVIDENCE SANTE (118.74) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
38.37x2022
2022
Q1: 0.0x
Med: 0.0x
Q3: 0.31x
Excellent
In 2022, the interest coverage of EVIDENCE SANTE (38.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution EVIDENCE SANTE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2013
2014
2015
2016
2017
2020
2021
2022
2023
2024
Operating WCR
276 502 €
266 993 €
514 489 €
601 467 €
609 629 €
0 €
0 €
59 721 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
0
0
Customer payment term (days)
104
95
139
142
163
0
0
193
0
0
Supplier payment term (days)
83
57
90
95
70
0
0
111
0
0
Positioning of EVIDENCE SANTE in its sector
Comparison with sector Conseil pour les affaires et autres conseils de gestion
Valuation estimate
Based on 69 transactions of similar company sales
in 2024,
the value of EVIDENCE SANTE is estimated at
1 440 623 €
(range 543 947€ - 3 606 288€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2024
69 tx
543k€1440k€3606k€
1 440 623 €Range: 543 947€ - 3 606 288€
NAF 5 année 2024
Valuation method used
Net Income Multiple
208 017 €
×
6.9x
=1 440 623 €
Range: 543 948€ - 3 606 288€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 69 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Conseil pour les affaires et autres conseils de gestion)
Compare EVIDENCE SANTE with other companies in the same sector:
Yes, EVIDENCE SANTE generated a net profit of 208 k€ in 2024.
Where is the headquarters of EVIDENCE SANTE ?
The headquarters of EVIDENCE SANTE is located in LAVAL (53000), in the department Mayenne.
Where to find the tax return of EVIDENCE SANTE ?
The tax return of EVIDENCE SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does EVIDENCE SANTE operate?
EVIDENCE SANTE operates in the sector Conseil pour les affaires et autres conseils de gestion (NAF code 70.22Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart